Skip to main content

Advertisement

SpringerLink
Log in

Myocardial Ischemia in Patients with Diastolic Dysfunction and Heart Failure

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Coronary artery disease is present in 40–55% of patients with diastolic heart failure, and myocardial ischemia is both a cause and a precipitant of diastolic heart failure. Failure to recognize and treat acute and chronic ischemia in patients with this disorder results in rapid disease progression and poor outcomes. In diastolic heart failure patients without obstructive coronary artery disease, ischemia can be induced by other diseases that diminish perfusion gradient, cause myocardium to outgrow blood supply, or decrease diastolic filling time. In this article, we review the role of ischemia and development of fibrosis in the epidemiology, pathophysiology, and evaluation of patients with diastolic dysfunction and diastolic heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. • Yancy CW, Lopatin M, Stevenson LW, et al.: Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006, 47:76–84. This provides registry data on incidence of DHF and ischemia.

    Article  PubMed  Google Scholar 

  2. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 2002, 105:1503–1508.

    Article  PubMed  Google Scholar 

  3. •• Jessup M, Abraham WT, Casey DE, et al.: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:1977–2016. These are the latest guidelines on treatment of patients with HF.

    Article  PubMed  Google Scholar 

  4. Ishii K, Suyama T, Imai M, et al.: Abnormal regional left ventricular systolic and diastolic function in patients with coronary artery disease undergoing percutaneous coronary intervention: clinical significance of post-ischemic diastolic stunning. J Am Coll Cardiol 2009, 54:1589–1597.

    Article  PubMed  Google Scholar 

  5. Khand AU, Gemmell I, Rankin AC, Cleland JG: Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges. Eur Heart J 2001, 22:153–164.

    Article  CAS  PubMed  Google Scholar 

  6. Yusuf S, Pfeffer MA, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003, 362:777–781.

    Article  CAS  PubMed  Google Scholar 

  7. McMurray JJ, Ostergren J, Swedberg K, et al.: Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003, 362:767–771.

    Article  CAS  PubMed  Google Scholar 

  8. Persson H, Lonn E, Edner M, et al.: Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 2007, 49:687–694.

    Article  PubMed  Google Scholar 

  9. Fonarow GC, Stough WG, Abraham WT, et al.: Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 2007, 50:768–777.

    Article  PubMed  Google Scholar 

  10. Bhatia RS, Tu JV, Lee DS, et al.: Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006, 355:260–269.

    Article  CAS  PubMed  Google Scholar 

  11. Gheorghiade M, Abraham WT, Albert NM, et al.: Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296:2217–2226.

    Article  CAS  PubMed  Google Scholar 

  12. Tribouilloy C, Rusinaru D, Mahjoub H, et al.: Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008, 29:339–347.

    Article  PubMed  Google Scholar 

  13. Gotsman I, Zwas D, Planer D, et al.: Clinical outcome of patients with heart failure and preserved left ventricular function. Am J Med 2008, 121:997–1001.

    Article  PubMed  Google Scholar 

  14. Peltier M, Houpe D, Cohen-Solal A, et al.: Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study. Int J Cardiol 2007, 118:363–369.

    Article  CAS  PubMed  Google Scholar 

  15. Soman P, Lahiri A, Mieres JH, et al.: Etiology and pathophysiology of new-onset heart failure: evaluation by myocardial perfusion imaging. J Nucl Cardiol 2009, 16:82–91.

    Article  PubMed  Google Scholar 

  16. Olivotto I, Cecchi F, Gistri R, et al.: Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006, 47:1043–1048.

    Article  PubMed  Google Scholar 

  17. Yoshida N, Ikeda H, Wada T, et al.: Exercise-induced abnormal blood pressure responses are related to subendocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 1998, 32:1938–1942.

    Article  CAS  PubMed  Google Scholar 

  18. Maron MS, Appelbaum E, Harrigan CJ, et al.: Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail 2008, 1:184–191.

    Article  PubMed  Google Scholar 

  19. •• Maron MS, Olivotto I, Maron BJ, et al.: The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009, 54:866–875. This is a description of similar findings in patients with HCM and DHF.

    Article  PubMed  Google Scholar 

  20. Zile MR, Brutsaert DL: New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002, 105:1387–1393.

    Article  PubMed  Google Scholar 

  21. Shah AM, Silverman HS, Griffiths EJ, et al.: cGMP prevents delayed relaxation at reoxygenation after brief hypoxia in isolated cardiac myocytes. Am J Physiol 1995, 268:H2396–H2204.

    CAS  PubMed  Google Scholar 

  22. Paulus WJ, Vantrimpont PJ, Shah AM: Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 1994, 89:2070–2078.

    CAS  PubMed  Google Scholar 

  23. Bonow RO, Bacharach SL, Green MV, et al.: Impaired left ventricular diastolic filling in patients with coronary artery disease: assessment with radionuclide angiography. Circulation 1981, 64:315–323.

    CAS  PubMed  Google Scholar 

  24. Carroll JD, Hess OM, Hirzel HO, et al.: Left ventricular systolic and diastolic function in coronary artery disease: effects of revascularization on exercise-induced ischemia. Circulation 1985, 72:119–129.

    CAS  PubMed  Google Scholar 

  25. Hutchins GM, Silverman KJ: Pathology of the stone heart syndrome. Massive myocardial contraction band necrosis and widely patent coronary arteries. Am J Pathol 1979, 95:745–752.

    CAS  PubMed  Google Scholar 

  26. Wukasch DC, Reul GJ, Milam JD, et al.: The “stone heart” syndrome. Surgery 1972, 72:1071–1080.

    CAS  PubMed  Google Scholar 

  27. Wexler LF, Weinberg EO, Ingwall JS, Apstein CS: Acute alterations in diastolic left ventricular chamber distensibility: mechanistic differences between hypoxemia and ischemia in isolated perfused rabbit and rat hearts. Circ Res 1986, 59:515–528.

    CAS  PubMed  Google Scholar 

  28. Smalling RW, Kelley KO, Kirkeeide RL, Gould KL: Comparison of early systolic and early diastolic regional function during regional ischemia in a chronically instrumented canine model. J Am Coll Cardiol 1983, 2:263–269.

    Article  CAS  PubMed  Google Scholar 

  29. He KL, Dickstein M, Sabbah HN, et al.: Mechanisms of heart failure with well preserved ejection fraction in dogs following limited coronary microembolization. Cardiovasc Res 2004, 64:72–83.

    Article  CAS  PubMed  Google Scholar 

  30. Wang J, Nagueh SF: Current perspectives on cardiac function in patients with diastolic heart failure. Circulation 2009, 119:1146–1157.

    Article  PubMed  Google Scholar 

  31. Abraham TP, Belohlavek M, Thomson HL, et al.: Time to onset of regional relaxation: feasibility, variability and utility of a novel index of regional myocardial function by strain rate imaging. J Am Coll Cardiol 2002, 39:1531–1537.

    Article  PubMed  Google Scholar 

  32. Voigt JU, Exner B, Schmiedehausen K, et al.: Strain-rate imaging during dobutamine stress echocardiography provides objective evidence of inducible ischemia. Circulation 2003, 107:2120–2126.

    Article  PubMed  Google Scholar 

  33. Ishii K, Imai M, Suyama T, et al.: Exercise-induced post-ischemic left ventricular delayed relaxation or diastolic stunning: is it a reliable marker in detecting coronary artery disease? J Am Coll Cardiol 2009, 53:698–705.

    Article  PubMed  Google Scholar 

  34. Azevedo CF, Amado LC, Kraitchman DL, et al.: Persistent diastolic dysfunction despite complete systolic functional recovery after reperfused acute myocardial infarction demonstrated by tagged magnetic resonance imaging. Eur Heart J 2004, 25:1419–1427.

    Article  PubMed  Google Scholar 

  35. Vinereanu D, Fraser AG, Robinson M, et al.: Adenosine provokes diastolic dysfunction in microvascular angina. Postgrad Med J 2002, 78:40–42.

    Article  CAS  PubMed  Google Scholar 

  36. Derumeaux G, Ovize M, Loufoua J, et al.: Doppler tissue imaging quantitates regional wall motion during myocardial ischemia and reperfusion. Circulation 1998, 97:1970–1977.

    CAS  PubMed  Google Scholar 

  37. •• Martos R, Baugh J, Ledwidge M, et al.: Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007, 115:888–895. This is a report on collagen turnover and diastolic dysfunction.

    Article  PubMed  Google Scholar 

  38. Asanuma T, Uranishi A, Masuda K, et al.: Assessment of myocardial ischemic memory using persistence of post-systolic thickening after recovery from ischemia. JACC Cardiovasc Imaging 2009, 2:1253–1261.

    Article  PubMed  Google Scholar 

  39. Wilson RM, De Silva DS, Sato K, et al.: Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. Hypertension 2009, 54:583–590.

    Article  CAS  PubMed  Google Scholar 

  40. Belardinelli L, Shryock JC, Fraser H: Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 2006, 92(Suppl 4):iv6–iv14.

    Article  CAS  PubMed  Google Scholar 

  41. Fraser H, Belardinelli L, Wang L, et al.: Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts. J Mol Cell Cardiol 2006, 41:1031–1038.

    Article  CAS  PubMed  Google Scholar 

  42. Fukuta H, Sane DC, Brucks S, Little WC: Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005, 112:357–363.

    Article  CAS  PubMed  Google Scholar 

  43. ClinicalTrials.gov: Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function (TOPCAT) Clinical Trial Summary. Available at http://clinicaltrials.gov/ct2/show/NCT00094302. Accessed February 2010.

  44. •• de Boer RA, Voors AA, Muntendam P, et al.: Galectin-3: a novel mediator of heart failure development and progression. Eur J Heart Fail 2009, 11:811–817. This is a review of galectin-3, a novel biomarker of fibrosis in HF.

    Article  PubMed  CAS  Google Scholar 

  45. Urano H, Ikeda H, Ueno T, et al.: Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. J Am Coll Cardiol 2001, 37:93–99.

    Article  CAS  PubMed  Google Scholar 

  46. Schneider C, Jaquet K, Geidel S, et al.: Transplantation of bone marrow-derived stem cells improves myocardial diastolic function: strain rate imaging in a model of hibernating myocardium. J Am Soc Echocardiogr 2009, 22:1180–1189.

    Article  PubMed  Google Scholar 

  47. Hedman A, Samad BA, Larsson T, et al.: Improvement in diastolic left ventricular function after coronary artery bypass grafting as assessed by recordings of mitral annular velocity using Doppler tissue imaging. Eur J Echocardiogr 2005, 6:202–209.

    Article  PubMed  Google Scholar 

  48. el-Said ES, Fioretti PM, Roelandt JR, et al.: Dobutamine stress—Doppler echocardiography before and after coronary angioplasty. Eur Heart J 1993, 14:1011–1021.

    CAS  PubMed  Google Scholar 

  49. Masoudi FA, Havranek EP, Smith G, et al.: Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003, 41:217–223.

    Article  PubMed  Google Scholar 

  50. McMurray JJ, Carson PE, Komajda M, et al.: Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 2008, 10:149–156.

    Article  PubMed  Google Scholar 

  51. Owan T, Hodge D, Herges R, et al.: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251–259.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Cardiovascular Medicine, Division of Nutrition and Preventive Medicine, William Beaumont Hospital, Third Floor West Tower, 3601 West 13 Mile Road, Royal Oak, MI, 48073, USA

    Thomas E. Vanhecke, Robert Kim, Shaheena Z. Raheem & Peter A. McCullough

Authors
  1. Thomas E. Vanhecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shaheena Z. Raheem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Peter A. McCullough
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas E. Vanhecke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vanhecke, T.E., Kim, R., Raheem, S.Z. et al. Myocardial Ischemia in Patients with Diastolic Dysfunction and Heart Failure. Curr Cardiol Rep 12, 216–222 (2010). https://doi.org/10.1007/s11886-010-0101-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-010-0101-1

Keywords

Search

Navigation